Takeda Pharmaceutical Income Statement
View: Annual
| Dec 06+ | Mar 05 | Mar 04 | |
|---|---|---|---|
| Revenue | 10,177.7 | 10,441.3 | 10,284.2 |
| Cost of Goods Sold | -- | 2,595.8 | 2,550.1 |
| Gross Profit | -- | 7,845.5 | 7,734.1 |
| Gross Profit Margin | 0.0% | 75.1% | 75.2% |
| SG&A Expense | -- | 4,263.2 | 4,216.2 |
| Depreciation & Amortization | -- | 290.3 | 265.8 |
| Operating Income | -- | 3,582.3 | 3,517.9 |
| Operating Margin | -- | 34.3% | 34.2% |
| Nonoperating Income | -- | 600.6 | 808.1 |
| Nonoperating Expenses | -- | 81.6 | 102.8 |
| Income Before Taxes | -- | 4,101.4 | 4,223.2 |
| Income Taxes | -- | 1,489.8 | 1,494.8 |
| Net Income After Taxes | 0.0 | 2,611.5 | 2,728.4 |
| Continuing Operations | -- | 2,611.5 | 2,728.4 |
| Discontinued Operations | -- | 0.0 | 0.0 |
| Total Operations | -- | 2,611.5 | 2,728.4 |
| Total Net Income | 2,630.0 | 2,579.6 | 2,700.3 |
| Net Profit Margin | 25.8% | 24.7% | 26.3% |
| Diluted EPS from Total Net Income ($) | -- | -- | -- |
| Dividends per Share | -- | -- | -- |
